A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses

A double-inactivated, candidate whole virus vaccine against severe acute respiratory syndrome associated coronavirus (SARS-CoV) was developed and manufactured at large scale using fermenter cultures of serum protein free Vero cells. A two step inactivation procedure involving sequential formaldehyde...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Vaccine
Egile Nagusiak: Spruth, Martin, Kistner, Otfried, Savidis-Dacho, Helga, Hitter, Elisabeth, Crowe, Brian, Gerencer, Marijan, Brühl, Peter, Grillberger, Leopold, Reiter, Manfred, Tauer, Christa, Mundt, Wolfgang, Barrett, P. Noel
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier Ltd. 2006
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7115667/
https://ncbi.nlm.nih.gov/pubmed/16214268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2005.08.055
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak